RT Journal Article
SR Electronic
T1 How many lives do COVID vaccines save? Evidence from Israel
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.27.21265591
DO 10.1101/2021.10.27.21265591
A1 Arbel, Ronen
A1 Moore, Candace Makeda
A1 Sergienko, Ruslan
A1 Pliskin, Joseph
YR 2021
UL http://medrxiv.org/content/early/2021/10/28/2021.10.27.21265591.abstract
AB Background In December 2020, Israel began a mass vaccination program with the rapid rollout of the Pfizer-BioNTech COVID-19 BNT162b2 vaccine for adults in Israel. The campaign vaccinated fewer people than necessary for herd immunity. However, at the same time, government stringency measures in terms of closing public life were decreased. Real-world observational data were used to examine the effect of mass vaccination on Covid-19 mortality.Methods The study period to examine the effect of vaccination on mortality was chosen to capture when at least 90% of the population over age 70 were vaccinated for less than seven months. Projected deaths as expected from vaccine efficacy and actual mortality data were compared for the study population with examination of potential confounding effects of government stringency. Average government stringency (Oxford Stringency Index) was calculated in the study period and the preceding period of the pandemic. Potential confounding effects of an age shift in the distribution of deaths were examined by analyzing the distributions of deaths and cases before and after the study period.Results Confirmed deaths from COVID-19 in the population over 70 after mass vaccination were recorded as 370, versus 408 expected from applying person-days of vaccine efficacy, and 5,120 estimated without vaccinations.Conclusions Vaccines against COVID-19 saved more lives than expected by simply applying individual vaccine efficacy to the vaccinated population in Israel, despite a loosening of government stringency.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Israeli National Institute of Health Policy.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data on a population level, which can be obtained from the Israel Ministry of Health and affiliated government websites.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study uses raw data obtained from the Israel Ministry of Health and affiliated government websites. All calculations on this data were made in Python 3.8 and are available as coded in publicly available Jupyter notebooks on the laboratory Github (9). https://github.com/maxcorlabs/Corona_Cost_Effectiveness